Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hospitalisation for SARS-COV2 infection | Other | Patients hospitalized for SARS-COV2 infection |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical characteristics | Describe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity | 34 months |
| Biological characteristics | Describe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity | 34 months |
| Radiological characteristics | Describe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity | 34 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patient hospitalised for Covid-19 | Inpatient up to Day 28 or discharge | 34 months |
| Overall Inpatient Mortality | Number of death due to Covid-19 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients hospitalized for SARS-COV2 infection
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Michel CARLES | Contact | +33492035847 | carles.m@chu-nice.fr | |
| Elisa DEMONCHY | Contact | demonchy.e@chu-nice.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de NICE - Infectiologie | Recruiting | Nice | 06200 | France |
No data sharing plan is scheduled
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D045169 | Severe Acute Respiratory Syndrome |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D006760 | Hospitalization |
| ID | Term |
|---|---|
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
| 34 months |
| Requirement for mechanical ventilation | Number of patients requiring mechanical ventilation | 34 months |
| ICU Length of Stay (LOS) | Duration measured in days | 34 months |
| Evolution of patient general state during hospitalisation | the different measures (Body Mass Index (BMI), respiratory rate at rest, peripheral oxygen saturation, need for oxygen supplementation, body temperature) will be aggregated in order to obtain a clinical status corresponding to the clinical evolution (good or bad) of the patient's general state. | 34 months |
| Biological tests | Dosage of Lymphocytes, C-reactive protein and IL-6 | 34 months |
| CHU de NICE - Urgences | Recruiting | Nice | 06200 | France |
|
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |